HPV 6, 11, 16, 18 vaccine in men. Inadequate assessment.
In a trial including 4065 men aged 16 to 26 years, HPV 6, 11, 16, 18 vaccination reduced the incidence of anogenital warts, but the preventive effect on cancer remains to be demonstrated.